Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China

References

• Davison AJ, Benko M, Harrach B.Genetic content and evolution of adenoviruses. J Gen Virol 2003;84: 2895–2908.
   PubMed Web of Science ®Google Scholar
• Tan D, Zhu H, Fu Yet al.Severe community-acquired pneumonia caused by human adenovirus in immunocompetent adults: a multicenter case series. PLoS One 2016;11: e0151199.
   PubMed Web of Science ®Google Scholar
• Kunz AN, Ottolini M.The role of adenovirus in respiratory tract infections. Curr Infect Dis Rep 2010;12: 81–87.
   PubMedGoogle Scholar
• Tebruegge M, Curtis N.Adenovirus infection in the immunocompromised host. Adv Exp Med Biol 2010;659: 153–174.
   PubMed Web of Science ®Google Scholar
• Chmielewicz B, Benzler J, Pauli Get al.Respiratory disease caused by a species B2 adenovirus in a military camp in Turkey. J Med Virol 2005;77: 232–237.
   PubMed Web of Science ®Google Scholar
• Lewis PF, Schmidt MA, Lu Xet al.A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14. J Infect Dis 2009;199: 1427–1434.
   PubMed Web of Science ®Google Scholar
• Jin Y, Zhang RF, Xie ZPet al.Prevalence of adenovirus in children with acute respiratory tract infection in Lanzhou, China. Virol J 2013;10: 271.
   PubMed Web of Science ®Google Scholar
• Lu QB, Tong YG, Wo Yet al.Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China, 2009-2012. Influenza Other Respir Viruses 2014;8: 302–308.
   PubMed Web of Science ®Google Scholar
• Chen M, Zhu Z, Huang Fet al.Adenoviruses associated with acute respiratory diseases reported in Beijing from 2011 to 2013. PLoS One 2015;10: e0121375.
   PubMed Web of Science ®Google Scholar
• Vanderveen J, Kok G.Isolation and typing of adenoviruses recovered from military recruits with acute respiratory disease in the Netherlands. Am J Hyg 1957;65: 119–129.
   PubMed Web of Science ®Google Scholar
• Metzgar D, Osuna M, Kajon AEet al.Abrupt emergence of diverse species B adenoviruses at US military recruit training centers. J Infect Dis 2007;196: 1465–1473.
   PubMed Web of Science ®Google Scholar
• Huang G, Yu D, Zhu Zet al.Outbreak of febrile respiratory illness associated with human adenovirus type 14p1 in Gansu Province, China. Influenza Other Respir Viruses 2013;7: 1048–1054.
   PubMed Web of Science ®Google Scholar
• Kajon AE, Lu X, Erdman DDet al.Molecular epidemiology and brief history of emerging adenovirus 14-associated respiratory disease in the United States. J Infect Dis 2010;202: 93–103.
   PubMed Web of Science ®Google Scholar
• Carr MJ, Kajon AE, Lu Xet al.Deaths associated with human adenovirus-14p1 infections, Europe, 2009-2010. Emerg Infect Dis 2011;17: 1402–1408.
   PubMed Web of Science ®Google Scholar
• Tang L, An J, Xie Zet al.Genome and bioinformatic analysis of a HAdV-B14p1 virus isolated from a baby with pneumonia in Beijing, China. PLoS One 2013;8: e60345.
   PubMed Web of Science ®Google Scholar
• Salama M, Amitai Z, Nutman Aet al.Outbreak of adenovirus type 55 infection in Israel. J Clin Virol 2016;78: 31–35.
   PubMed Web of Science ®Google Scholar
• Lafolie J, Mirand A, Salmona Met al.Severe pneumonia associated with adenovirus type 55 infection, France, 2014. Emerg Infect Dis 2016;22: 2012–2014.
   PubMed Web of Science ®Google Scholar
• Walsh MP, Seto J, Jones MSet al.Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen. J Clin Microbiol 2010;48: 991–993.
   PubMed Web of Science ®Google Scholar
• Cao B, Huang G-H, Pu Z-Het al.Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia. Chest 2014;145: 79–86.
   PubMed Web of Science ®Google Scholar
• Schildgen O, Gu L, Qu Jet al.Sustained viremia and high viral load in respiratory tract secretions are predictors for death in immunocompetent adults with adenovirus pneumonia. Plos One 2016;11: e0160777.
   PubMed Web of Science ®Google Scholar
• Liu J, Nian QG, Zhang Yet al.In vitro characterization of human adenovirus type 55 in comparison with its parental adenoviruses, types 11 and 14. PLoS One 2014;9: e100665.
   PubMed Web of Science ®Google Scholar
• Radke JR, Yong SL, Cook JL.Low-level expression of the E1B 20-kilodalton protein by adenovirus 14p1 enhances viral immunopathogenesis. J Virol 2016;90: 497–505.
   PubMed Web of Science ®Google Scholar
• Aste-Amezaga M, Bett AJ, Wang Fet al.Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines. Hum Gene Ther 2004;15: 293–304.
   PubMed Web of Science ®Google Scholar
• Sun C, Zhang Y, Feng Let al.Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China. Vaccine 2011;29: 3837–3841.
   PubMed Web of Science ®Google Scholar
• Su XB, Tian XG, Jiang ZXet al.Human adenovirus serotype 3 vector packaged by a rare serotype 14 hexon. Plos One 2016;11: e0156984.
   PubMed Web of Science ®Google Scholar
• Yu B, Dong J, Wang Cet al.Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera. Virology 2013;437: 118–123.
   PubMed Web of Science ®Google Scholar
• Zhang S, Huang W, Zhou Xet al.Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults. J Med Virol 2013;85: 1077–1084.
   PubMed Web of Science ®Google Scholar
• Mupapa K, Massamba M, Kibadi Ket al.Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J Infect Dis 1999;179: S18–S23.
   PubMed Web of Science ®Google Scholar
• Zhou BP, Zhong NS, Guan Y.Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 2007;357: 1450–1451.
   PubMed Web of Science ®Google Scholar
• Mast TC, Kierstead L, Gupta SBet al.International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials. Vaccine 2010;28: 950–957.
   PubMed Web of Science ®Google Scholar
• Abbink P, Lemckert AA, Ewald BAet al.Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J Virol 2007;81: 4654–4663.
   PubMed Web of Science ®Google Scholar
• Thorner AR, Vogels R, Kaspers Jet al.Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa. J Clin Microbiol 2006;44: 3781–3783.
   PubMed Web of Science ®Google Scholar
• Wang X, Xing M, Zhang Cet al.Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China. Emerg Microbes Infect 2014;3: e30.
   PubMed Web of Science ®Google Scholar
• Huang D, Hennequi M, Elvachev Aet al.The sero-prevalence of anti-adenovirus 5 neutralizing antibodies is independent of a chronic hepatitis B carrier state in China. Arch Virol 2015;160: 1125–1130.
   PubMed Web of Science ®Google Scholar
• Kajon AE, Dickson LM, Metzgar Det al.Outbreak of febrile respiratory illness associated with adenovirus 11a infection in a Singapore military training cAMP. J Clin Microbiol 2010;48: 1438–1441.
   PubMed Web of Science ®Google Scholar
• Tian X, Jiang Z, Ma Qet al.Prevalence of neutralizing antibodies to common respiratory viruses in intravenous immunoglobulin and in healthy donors in southern China. J Thorac Dis 2016;8: 803–812.
   PubMed Web of Science ®Google Scholar
• Yang W-X, Zou X-H, Jiang S-Yet al.Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions. Vaccine 2016;34: 5579–5586.
   PubMed Web of Science ®Google Scholar
• Shirato H.Norovirus and histo-blood group antigens. Jpn J Infect Dis 2011;64: 95–103.
   PubMed Web of Science ®Google Scholar
• Branch DR.Blood groups and susceptibility to virus infection: new developments. Curr Opin Hematol 2010;17: 558–564.
   PubMed Web of Science ®Google Scholar
• Wang D-S, Chen D-L, Ren Cet al.ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer 2012;131: 461–468.
   PubMed Web of Science ®Google Scholar
• Roberts DM, Nanda A, Havenga MJet al.Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature 2006;441: 239–243.
   PubMed Web of Science ®Google Scholar
• Qiu H, Li X, Tian Xet al.Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions. J Virol 2012;86: 7964–7975.
   PubMed Web of Science ®Google Scholar
• Bradley RR, Lynch DM, Iampietro MJet al.Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection. J Virol 2012;86: 625–629.
   PubMed Web of Science ®Google Scholar
• Cheng C, Gall JG, Nason Met al.Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization. J Virol 2010;84: 630–638.
   PubMed Web of Science ®Google Scholar